DNA test links genes to suicide in antidepressant users

When a patient first begins to take antidepressants, there is actually a chance that person may commit suicide within the first two weeks — it’s known as medication-induced suicide.

The risk increases during this recovery period, and scientists have not known why in the past. According to the Max Planck Institute of Psychiatry, 59 percent of patients committed suicide within two weeks of initial treatment, and 8 percent experienced the adverse effects of medication when they first began taking them.

The company Sundance Diagnostics plans to enter a licensing agreement with the Max Planck Institute of Psychiatry to bring a new suicidality test into the market. The suicidality test would be able to identify a person’s suicide risk based on certain gene markers.

Read the full, original story: New ‘Suicidality’ Test Predicts Antidepressant-Induced Suicide Risk In Patients

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...

Most Popular

News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend